SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), a leading data collaboration platform, today announced that its CFO Lauren Dillard will present at the Wells Fargo 9th Annual TMT Summit in Rancho Palos Verdes, CA on Tuesday, November 18th at 12:45 p.m. PT / 3:45 p.m. ET. Links to the live webcast of the presentation and a replay will be available on LiveRamp’s investor relations website. About LiveRamp LiveRamp is a leading data collaboration technology company, empowering marketers ...

核心观点 - 公司在2026财年第一季度实现强劲财务表现 收入增长151% 盈利能力显著改善 从去年同期净亏损转为净盈利 [1][2][3] - 管理层将业绩归因于严格的执行 对人员和技术的持续投资 以及业务增长的势头 [2] - 公司确认了2026财年的财务指引 预计收入在9亿至95亿美元之间 调整后EBITDA在5600万至6500万美元之间 [4][5] 财务业绩总结 - 总收入为2361亿美元 较2025财年同期的2051亿美元增长151% [2][3] - 税前利润为790万美元 较去年同期税前亏损530万美元增长2492% [2][3] - 净利润为770万美元 去年同期净亏损为570万美元 净利润率为32% 较去年同期的净亏损率28%提升60个百分点 [2][3] - 归属于公司的净利润为800万美元 每股收益为006美元 去年同期净亏损为490万美元 每股亏损为004美元 [2][3] - 中心级贡献利润为5136亿美元 同比增长487% 利润率从168%提升至218% [2][3] - 调整后EBITDA为1764亿美元 较去年同期的647亿美元增长112亿美元 利润率从32%提升至75% [2][3] 运营指标与财务状况 - 参与者人数约为7890人 较去年同期的7210人有所增加 [3] - 期末现金及现金等价物为671亿美元 短期投资为423亿美元 债务为715亿美元 [3] - 总成员月数被管理层用作跟踪年度服务参与者数量的指标 [6] 非GAAP指标说明 - 中心级贡献利润定义为总收入减去外部供应商成本和扣除折旧摊销后的护理成本 用于评估各运营分部绩效和资源分配 [16] - 调整后EBITDA在净利润基础上调整了利息支出 折旧摊销 所得税以及股权补偿 诉讼成本等非经常性项目 [17][23] 2026财年业绩指引 - 预计参与者人数在7900至8100人之间 [5] - 预计总成员月数在91600至94400个月之间 [5] - 预计总收入在9亿至95亿美元之间 [5] - 预计调整后EBITDA在5600万至6500万美元之间 [5]

Operational efficiencies drive $15.0 million of year-to-date improved cash flow from operating activities and $13.2 million increase in adjusted EBITDA, strengthening the foundation for efficient growth aheadDENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today reported results for the third quarter (“Q3 2025”) ended September 30, 2025. Q3 2025 Highlights: Net loss of $4.5 milli ...

Latham Outperforms the U.S. In-Ground Pool Market With Strong Third Quarter ResultsNet Sales Growth of 7.6%, Including Organic Growth of 4.7%Gross Margin Expanded by 300 Basis Points Third Quarter 2025 Financial Highlights: Net sales of $161.9 million up 7.6%Net income of $8.1 million up 37.7% / Earnings per diluted share of $0.07 vs. $0.05 in prior yearAdjusted EBITDA of $38.3 million up 28.5% reaching 23.7% of net sales Nine Months 2025 Financial Highlights: Net sales of $446.0 million up 5.9%Net income ...

Than Powell Than Powell, CBO, Longeveron On track for top-line trial results in the third quarter of 2026 from pivotal Phase 2b clinical trial ELPIS II. ELPIS II is evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indication and is fully enrolled.ELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacyCompany to host conference ...

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it has been named a BioSpace 2026 Best Place to Work. “Protara is thrilled to be recognized as one of the most sought-after biotech employers in the life sciences community,” said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics. “Our colleagues are crucial to every aspect of ou ...

核心观点 - 公司2026财年第一季度业绩表现强劲，经常性及其他收入同比增长14%，盈利能力显著提升，这得益于其差异化的现代软件价值主张和人工智能战略的持续推进 [2] - 公司宣布了更新的长期财务目标，显著提高了对总收入和利润率（如调整后税息折旧及摊销前利润和自由现金流）的预期，反映出管理层对公司持续增长和规模效应的信心 [7][10] - 公司在第一季度进行了2亿美元的股份回购，并自2024年5月以来累计回购了5亿美元股份，显示出其强大的现金流生成能力和资本回报意愿 [7] 第一季度财务业绩 - **收入表现**：第一季度总收入为4.082亿美元，同比增长12%；经常性及其他收入为3.789亿美元，同比增长14% [3][7][8] - **盈利能力**：GAAP营业利润为7420万美元，非GAAP营业利润为1.212亿美元，均高于上年同期的6410万美元和1.049亿美元 [3]；调整后税息折旧及摊销前利润为1.464亿美元，高于上年同期的1.29亿美元 [9] - **净利润与每股收益**：GAAP净利润为4800万美元，摊薄后每股收益为0.86美元；基于5590万摊薄加权平均流通股 [4] - **资产负债表**：截至2025年9月30日，现金及现金等价物为1.652亿美元，长期债务为8130万美元，该债务主要用于2024年10月1日对Airbase的收购，并在本季度偿还了约8130万美元 [9] - **现金流**：第一季度经营活动产生的净现金为8650万美元，略低于上年同期的9150万美元 [9] 长期财务目标更新 - **收入目标**：长期总收入目标从之前的"20亿美元以上"提升至30亿美元 [10] - **利润率目标**：调整后税息折旧及摊销前利润率目标从35%-40%提升至40%-45%；自由现金流利润率目标从20%-25%提升至25%-30% [10] - **费用控制目标**：非GAAP销售与营销费用占收入比例目标从20%-25%降至15%-20%；股权激励支出目标从低于10%降至5% [10] - **其他目标**：调整后毛利率目标提升至80%以上；非GAAP研发支出和一般行政费用目标范围基本维持不变 [10] 业务展望与战略重点 - **第二季度展望**：预计经常性及其他收入在3.785亿至3.835亿美元之间（同比增长约10%）；总收入在4.055亿至4.105亿美元之间（同比增长约8%）；调整后税息折旧及摊销前利润在1.315亿至1.355亿美元之间 [12][15] - **2026财年全年展望**：预计经常性及其他收入在16.05亿至16.20亿美元之间（同比增长约10%）；总收入在17.15亿至17.30亿美元之间（同比增长约8%）；调整后税息折旧及摊销前利润在6.15亿至6.25亿美元之间 [12][15] - **人工智能战略**：人工智能战略持续取得进展，提供预测性和可操作的洞察、生成式人工智能功能以及越来越多的自主代理，通过超越基本搜索的任务和工作流自动化来提高生产力 [2] - **新产品反馈**：Paylocity for Finance解决方案获得了早期积极市场反馈，其管理所有支出和关键业务工作流的价值主张得到了客户和潜在客户的认可 [2]

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc., a technology company in defense, national security, and global markets, announced today that it has signed a definitive agreement to acquire 100 percent of the ordinary shares of Orbit Technologies Ltd (ORBI.TA) for $356.3 million, which is expected to be funded via cash on Kratos’ balance sheet. Orbit is a leading global provider of mission-critical satellite-based communication systems for mobile and unmanned aerial, s ...

PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced the start date of its new CEO and related board changes. Effective November 1, 2025, Olivier te Boekhorst began serving as President and CEO of the Company, succeeding Michael F. Brigham. At its ...

MILWAUKEE, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended September 30, 2025. Third Quarter 2025 Overview Net sales: $73.1 million (down 2% from $74.3 million in Q3 2024)Gross earnings: 40.7% of net sales (compared to 44.3% of net sales in Q3 2024)Earnings from operations: $8.1 million (down 21% compared to $10.2 million in Q3 2024)Net earnings: $6.6 million (down 18% from $8.1 million in Q3 202 ...